Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate

BACKGROUND: Mucin glycoprotein 1 (MUC1) is a glycosylated transmembrane protein on epithelial cells. We investigate MUC1 as a therapeutic target in Barrett’s epithelium (BE) and esophageal adenocarcinoma (EA) and provide proof of concept for a light based therapy targeting MUC1. RESULTS: MUC1 was pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Mohammed Adil, Pye, Hayley, Haidry, Rehan J., Oukrif, Dahmane, Khan, Saif-U-Rehman, Puccio, Ignazio, Gandy, Michael, Reinert, Halla W., Bloom, Ellie, Rashid, Mohammed, Yahioglu, Gokhan, Deonarain, Mahendra P., Hamoudi, Rifat, Rodriguez-Justo, Manuel, Novelli, Marco R., Lovat, Laurence B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421911/
https://www.ncbi.nlm.nih.gov/pubmed/28212575
http://dx.doi.org/10.18632/oncotarget.15340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421911/
https://www.ncbi.nlm.nih.gov/pubmed/28212575
http://dx.doi.org/10.18632/oncotarget.15340

Ejemplares similares